Irregular Ventricular Stimulation in the DDI Mode of a Dual Chamber Pacemaker With Atrial-Based Lower Rate Timing

This report describes two patients with atrial fibrillation in whom an implanted CHORUS DDD pacemaker programmed to the DDI mode produced an irregular ventricular stimulation rate. The lower rate timing of these devices is atrial-based only when an atrial event opens an AV interval shorter than the programmed AV delay. In the DDI mode, if Api represents the time when an atrial paced event (Ap) would have occurred if it had not been inhibited by a previous atrial sensed event (As), then Api-Vp constitutes the implied AV interval where Vp is a paced ventricular event. Although the As-Vp interval (As-Api+Api-Vp) generates an atrial refractory period during its entire duration, the pacemaker can sense an atrial event (A r ) during the implied AV interval. A r cannot start another AV delay, but it can initiate the atrial-based lower rate interval. This timing mechanism can cause irregular prolongation of Vp-Vp intervals to a value longer than the programmed lower interval with a maximal extension equal to the programmed AV delay. Such behavior of the CHORUS pacemaker should not be interpreted as malfunction.     

Intermittent Pacemaker Syndrome: Revision of VVI Pacemaker to a New Cardiac Pacing Mode for Tachy-Brady Syndrome

A patient with tachy-brady syndrome manifested by paroxysmal atrial fibrillation and symptomatic sinus bradycardia and treated by VVI pacing developed pacemaker syndrome during episodes of ventricular pacing. His cardiac pacemaker was revised to a dual chamber system utilizing the new AV sequential DDI pacing mode which eliminated pacemaker-related tachycardias and totally abolished the pacemaker syndrome symptoms. There have been no further episodes of atrial fibrillation, possibly due to elimination of temporal dispersion of refractory periods during bradycardia. The propensity for atrial fibrillation has also been minimized by excluding competitive atrial stimulation during DVI pacing. The DDI mode provides the clinician increased utility and flexibility in the use of AV sequential pacing therapy.     

Interpretation of Dual Chamber Pacemaker Electrocardiograms

A diagramming system has been developed to assist in interpreting dual chamber pacemaker electrocardiograms. The system is based on the ladder diagram principle but uses two separate ladders, one for the ECG allowing proper representation of atrial A-V and ventricular activation, and a second ladder diagram below it for pacemaker events. The system is applicable to all current single and dual chamber pacing modes and is easy to draw. The ladder diagram allows the logical sequence of timing events to be easily illustrated, and pacemaker malfunction becomes clearly recognizable as a conflict between the ECG events ladder and the pacemaker timing ladder. The system is easy to apply and may eventually prove suitable for automatic generation by computer utilizing sophisticated pacemaker telemetry.     

Inappropriate Ventricular Blanking in a DDI Pacemaker

The DDI mode is a new pacing mode with potential advantages over DVI pacing. We describe anomalous post R wave ventricular pacing due to the presence of inappropriate ventricular blanking periods in a pacemaker programmed to the DDI mode. Although no adverse consequences were seen in our patients, potentially dangerous R-on-T pacing could occur, particularly if long atrioventricular delays are programmed. A method for eliminating this pacing anomaly is described. Patients programmed to the DDI mode with the pacemaker model described should be evaluated for post R wave ventricular pacing and corrective measures should be taken.     

Early Complications After Dual Chamber Versus Single Chamber Pacemaker Implantation

This study was performed to compare the frequency of early complications after single chamber versus dual chamber permanent pacemaker implantation. Early complication was defined as one occurring in the 6-week period following implantation. We prospectively analyzed consecutive pacemaker implantation from January 1987 to June 1993 at our regional center. All complications were also analyzed for the relationship to operator experience, the venous access route, and the presence of temporary pacing wire at the time of implantation of the permanent pacing system. A total of 2019 new pacemaker units were implanted during this period. 1733 patients (85.8%) received a VVI pacemaker and 286 (14.2%) a DDD unit. Wound infection occurredin 11 (0.6%) VVI patients and 6 (2.1%) DDD patients. Lead displacement occurred in 18(1 %) VVI patients and 15 (5.2%) DDD patients (11 [3.8%] atrial and 4 [1.4 %] ventricular). There were 10 (0.6%)pneumothoraces, 9 (0.5%) hematomas requiring drainage, 1 (0.06%) chylocele, and 2 (0.1%) deaths in the VVI group. There were 2 (0.7%) pneumothoraces, 2 (0.7%) hematomas, and no deaths in the DDD group. There was no significant increase in complications for experienced infrequent implanters (< 12 systems per year). In both groups the subclavian approach was associated with a risk of pneumothorax when compared to the cephalic approach. The rate of wound infection was higher in patients who had a temporary pacing wire in place. The use of prophylactic antibiotics does not appear to affect the incidence of wound infection. The early complications in the DDD group were higher than in the VVI group (8.7% vs 2.9%, P < 0.05), being mainly due to an increased incidence of wound infection and atrial lead displacement.     

Double Ventricular Pacing in a Patient with a "DDD" Universal Pacemaker

A patient with a DDD universal pacemaker presented with dyspnea. The electrocardiogram showed pacing artifacts both at the start of the QRS complex and 110 ms later. Also, 400 ms following sensed ventricular extrasystoles, there were normal single paced QHS complexes of slightly different morphology. An x-ray showed that the atrial electrode had displaced into the ventricle, and at exploration this was found to be due to late retraction of the electrode's active fixation helix. Following implantation of a new atrial lead, normal DDD pacing function was restored and the patient became asymptomatic.     

Implantation of a Dual Chamber Pacemaker in a Patient with Persistent Left Superior Vena Cava

A patient underwent dual chamber pacemaker implantation by puncture of the left subclavian vein. During the procedure we observed persistence of the left superior vena cava. A "J-shaped" atrial lead was used for ventricular pacing with excellent long-term results. This technique can be a valuable alternative when confronted with the problem of persistent left superior vena cava during pacemaker implantation.     

Atrial Capture and Dual Chamber Pacing

During dual chamber pacing it is sometimes impossible to assess atrial capture even on the 12-lead ECG. We developed a strategy to identify atrial capture when it is not possible to do so by ECG, and when the ECG shows no evidence of spontaneous or paced atrial activity.     

Particularities of Dual Chamber Pacemaker Therapy in Patients after Orthotopic Heart Transplantation

Since August 1981, 33 orthotopic heart transplantations were performed in our hospital. Three of these patients (9%) had sinus bradycardias with rates as low as 30 beats/min; they were treated by implantation of a dual chamber pacemaker. These patients had two atria as a result of orthotopic heart transplantation, but only the donor atrium was suitable for positioning the atrial lead. In the postoperative period, some nonsurgical complications were observed in one patient who developed atrial fibrillation which we treated with drugs. A cyclosporin-evoked tremor produced several asystoles due to false inhibition by myopotential interference in the VVI mode. During an episode of acute rejection combined with renal insufficiency, loss of atrial and ventricular sensing occurred. The other patients showed no pacemaker-related complications. Our findings in this unique population of pacemaker patients are discussed.     

Carotid Sinus Syndrome: Acute Hemodynamic Evaluation of a Dual Chamber Pacing Mode

Cardiac pacing is the treatment of choice in patients with carotid sinus syndrome (CSS), Three different pacing modes were tested in 20 patients (16 males, 4 females; mean age 75 ± 9 years) with documented symptomatic CSS, Three carotid sinus massages (CSM) were performed in each supine patient successively paced in random order in: DDI—the reference pacing mode; DDD—automatic mode conversion (DDD/AMC) allowing automatic switching from AAI to DDD when AV block occurs; DDD/AMC plus a trial acceleration (DDD/AMC + ace); and OOO (CSM without pacing) to determine whether the vasodepressive effect was still present 10 minutes after the preceding CSM. Intraarterial blood pressure was continuously monitored. Results were expressed as the value of the mean systolic BP at TO + 3 s + 6 s … TO + 30 s divided by the value of the mean systolic blood pressure prior to onset of CSM. The drop in arterial blood pressure was more severe in the DDI mode than in DDD/AMC (P < 0,001) and DDD/AMC + acc (P < 0.0001) in 20 patients. In the OOO mode, the drop in arterial blood pressure was most marked and greater than in the DDI mode (P < 0.0001). The average time between start of the CSM and onset of the drop in blood pressure was the same in the three dual chamber modes. We conclude that the DDD/AMC mode significantly improves the vasodepressor response to CSM compared to the DDI mode. There is a current trend favoring DDD/AMC + acc over DDD/AMC.     

Complications after Single versus Dual Chamber Pacemaker Implantation

To compare the complication rate in patients having a dual chamber versus a single chamber pacing system, 337 consecutive procedures performed during a 3-year period were analyzed prospectively. Two hundred fifty-eight patients (77%) received a VVI pacemaker and 75 (23%) a DDD unit. Thirteen VVI (5%) and 4 DDD (5.3%) needed reintervention. Lead displacement with reoperation was required for three ventricular leads (1%) and one atrial lead (1.3%). Infection occurred in two VVI units (0.77%) and one DDD (1.33%) unit. Muscular stimulation was noticed among three DDD (4%) and nine VVI systems (3.5%). Urgent reprogramming was needed for 23 VVI (9%) and six DDD units (8%). There was no increase in complications with dual chamber pacing compared to single chamber systems.     

Improved Dual Chamber Pacing Mode in Paroxysmal Atrioventricular Conduction Disorders

GIRODO, S., ET AL.: Improved Dual Chamber Pacing Mode in Paroxysmal Atrioventricular Conduction Disorders. Dual chamber pacing may sometimes be directly indicated for carotid sinus hypersensitivity, vasovagal syndrome, and certain cases of sinoatrial block and intermittent atrioventricular (AV) block, although AV conduction is dominantly normal. At times of normal AV conduction, competition between ventricular pacing and spontaneous ventricular depolarization may occur, with its adverse hemodynamic effects on ventricular function and unnecessary drainage of pacemaker battery energy. A new mode of stimulation is described, called automatic DDD mode, which functions in 'pseudo-AAI' mode during normal AV conduction and reverts to classical DDD function during episodes of AV blocks. Furthermore, during pseudo-AAI function, the pacemaker measures certain physiological parameters that serve to automatically program certain parameters used in DDD mode. Preliminary clinical evaluation has shown that this new mode functions satisfactorily.     

Clinical Evaluation of an Automatic Sensitivity Adjustment Feature in a Dual Chamber Pacemaker

The clinical evaluation of a new automatic sensitivity adjustment feature in the Cosmos II, Model #284-05 is described. This feature, designed to maintain a 2:1 safety margin for sensing intrinsic signals, was activated by way of special programmer software in ten patients at two centers. While the feature worked satisfactorily in some cases, it did not perform as expected, and undersensing in both chambers was observed. This may have been due to biasing the adjustment toward maximum rather than minimum electrograms. This study suggested that electrograms may vary by more than 100% which underscores the importance of this feature, and reinforces the need for continued development.     

Clinical Interest of a Sensor Driven Algorithm Limiting Ventricular Pacing Rate During Supraventricular Tachycardia in Dual Chamber Pacing

A sensor driven algorithm limiting ventricular pacing rate during supraventricular tachycardia (SVT) is included in a dual chamber rate modulated pacemaker sensitive to acceleration forces (Relay, 294-03, Intermedics Inc.). According to the intensity of concomitant exercise, the ventricular pacing rate is limited either to the programmed maximum pacing rate (MPR) or to an interim lower limit, called "conditional ventricular tracking limit" (CVTL). The MPR prevails over the CVTL when the sensor calculated pacing rate exceeds the minimal rate by more than 20 beats/mm. The purpose of the study is to determine the clinical safety and efficacy of this algorithm in patients with intermittent SVT. Method: a Relay was implanted in four patients with a bradycardia/tachycardia syndrome and in four patients with complete atrioventricular block (CAVB). All had episodes of paroxysmal atrial tachycardia. The units were programmed in DDDR: rate responsive parameters were adjusted by simulating the rate response during three levels of exercise to let the MPR override the CVTL only during strenuous exercise. Holter monitors and exercise testings were performed at 3-month follow-up. Results: in seven patients, Holter recordings showed Supraventricular arrhythmias at rest with a ventricular pacing rate limited to the CVTL. Appropriate rate increases during exercise testings were also demonstrated. Three devices had to be reprogrammed in DDIR tone patient suffering from nearly permanent atrial flutter and two patients not tolerating the CVTL pacing rate at rest). Conclusion: the CVTL algorithm is effective in protecting against high ventricular pacing rates during Supraventricular arrhythmias. It allows the selection of the DDDR mode even with a high MPR in patients with intermittent SVT.     

Computer Simulation of Cardiac Pacing

A mathematical model of the cardiac conduction system, including external pacemakers, has been developed. The heart is modeled as a network in which the impulse propagation is described by differential equations; several arrhythmia-generating mechanisms, such as modulated parasystole, reflection, macro and micro re-entry and block, can be simulated. Different kinds of pacemaker modes have been incorporated in the model, thus making it possible to simulate the interaction between the heart and the pacemaker. The model can be tuned by the user according to electrophysiological data so that pacemaker programs can be tested under different underlying conditions. During a simulation, the program generates ECG signals and pacemaker diagnostic diagrams. This model can be used for training and testing, and also as a support system when searching for the optimal pacing therapy for a particular patient.     

Transvenous Dual Chamber Pacing via a Unilateral Left Superior Vena Cava

A 74-year-old woman with a unilateral left superior vena cava required dual chamber permanent pacing after a radical cardiac operation for an incomplete form of endocardial cushion defect. An active fixation ventricular lead was used to prevent the instability induced by the strange course of the electrode. For atrial pacing, a ventricular passive fixation lead was used. A transvenous dual chamber pacemaker was successfully inserted via a unilateral left superior vena cava.     

Does Dual Chamber or Atrial Pacing Prevent Atrial Fibrillation? The Need for a Randomized Controlled Trial

Partially due to recent reports that cardiac antiarrhythmic therapy may have adverse effects on patient survival, clinicians have become more interested in the nonpharmacological prevention of atrial fibrillation. There is a large body of literature that suggests that the rate of development of atrial fibrillation in paced sick sinus syndrome patients is much lower in those patients who have received an atrial-based system, rather than a VVI system. However, all the published studies to date are retrospective, and fraught with potential bias favoring the AAI or DDD group. The authors strongly believe that the only way to determine if these suggestive but uncertain retrospective analyses are correct is to apply the same scientific rigor to this problem as has been applied to many other problems in cardiovascular medicine and perform a prospective randomized trial. A proposed trial design is discussed.     

Computer Simulation of Dual Chamber Pacemaker Algorithms Using a Realistic Heart Model

Single and dual chamber pacing algorithms have been incorporated into a realistic computer model of cardiac electrical activation. The model enables different pacemaker algorithms to be tested, it allows prediction of their behavior, and it produces a simulated ECG record for each case. The computer model has been used to test eight different modifications of a simple DDD mode to prevent or terminate pacemaker-mediated "endless loop" tachycardia: (1) constant prolongation of the atrial channel refractory period; (2) prolongation of the atrial refractory period after a ventricular premature beat (VPB); (3) atrial pacing synchronously with a VPB; (4) simple rate control; (5) rate control in which the VA counter is not reset; (6) no ventricular pacing after an atrial premature beat; (7) rate limitation of atrial sensing; and (8) a combination of DDD and high frequency atrial stimulation modes. These modifications were tested with VPBs, atrial premature beats, atrial stimulation without capture, and accelerating sinus tachycardia. Only the pacemaker designed not to pace the ventricles following an atrial premature beat behaves satisfactorily in all four circumstances. Further possibilities for the development and use of a pacemaker-oriented computer heart model are discussed.     

Radionuclide Evaluation of Dual Chamber Pacing: Comparison Between Variable AV Intervals and Ventricular Pacing

We prospectively evaluated changes in left ventricular ejection fraction, end diastolic volume, and stroke volume via radionuclide multigated acquisition study, Comparison was made between ventricular pacing and dual chamber pacing with varying AV intervals. The volumes and changes in ejection fraction were determined at rest, at set increased pacing rates, and during physiological stress. AV sequential pacing shows overall improvement in cardiac function in the majority of patients regardless of left ventricular function. The shorter AV interval would be appropriate for the majority of patients who have an atrial tracking mechanism (adequate intrinsic sensed atrial activity followed by ventricular pacing) and who undergo significant physiological stress.     

Ventricular Cross Stimulation in a Dual Chamber Pacing System: Phenomenon Analysis

Seven cases of ventricular cross stimulation from a group of 23 patients implanted with DDD devices are presented. In two patients the phenomenon was observed at the moment of DDD programming at nominal values, and in five other patients it was reproduced by increasing the atrial output voltage up to ten volts. In all 23 patients cross stimulation disappeared permanently within 24 hours after implantation. From the onset of cross stimulation to its end, atrial and ventricular threshold voltages were unchanged, while the atrial and ventricular impedances significantly decreased. These results suggest that an important role in the phenomenon occurs by impedance variation at the interface between the pulse generator and body tissue.